Candel Therapeutics (CADL) Interest & Investment Income (2020 - 2025)
Candel Therapeutics (CADL) reported Interest & Investment Income of $1.1 million for Q4 2025, up 280.0% on a YoY basis from $290000.0 in Q4 2024, and up 15.63% sequentially from $953000.0 in Q3 2025.
Candel Therapeutics (CADL) Interest & Investment Income (2020 - 2025) Analysis & Trends
Candel Therapeutics (CADL) has 6 years of Interest & Investment Income data on file, last reported at $1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income rose 280.0% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.9 million (up 260.5% YoY), and the FY2025 full-year result was $3.9 million, up 260.5% from the prior year.
- Interest & Investment Income grew to $1.1 million in Q4 2025, from $953000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q4 2025 to a low of -$366000.0 in Q4 2022.
- A 5-year average of $302736.8 and a median of $236000.0 in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 3375.0% in 2021 and plunged 345.64% in 2022, its largest moves.
- Tracing CADL's Interest & Investment Income over 5 years: stood at $149000.0 in 2021, then sank by 345.64% to -$366000.0 in 2022, then surged by 213.39% to $415000.0 in 2023, then plunged by 30.12% to $290000.0 in 2024, then surged by 280.0% to $1.1 million in 2025.
- Business Quant data shows CADL's Interest & Investment Income at $1.1 million in Q4 2025, $953000.0 in Q3 2025, and $926000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Candel Therapeutics | 530.65 Mn | 530.65 Mn | - | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 953,000.00 |
| Jun 30, 2025 | 926,000.00 |
| Mar 31, 2025 | 934,000.00 |
| Dec 31, 2024 | 290,000.00 |
| Sep 30, 2024 | 236,000.00 |
| Jun 30, 2024 | 240,000.00 |
| Mar 31, 2024 | 320,000.00 |
| Dec 31, 2023 | 415,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | -366,000.00 |
| Sep 30, 2022 | 343,000.00 |
| Jun 30, 2022 | 70,000.00 |
| Dec 31, 2021 | 149,000.00 |
| Sep 30, 2021 | 131,000.00 |
| Jun 30, 2021 | -15,000.00 |
| Mar 31, 2021 | -12,000.00 |
| Dec 31, 2020 | 42,000.00 |